Analysis of the Results of Hepatitis B and C Molecular Tests in Southern Iran from 2018 to 2022, the Possibility of Hepatitis C Genotype Change in the Region

对2018年至2022年伊朗南部乙型和丙型肝炎分子检测结果的分析,以及该地区丙型肝炎基因型发生变化的可能性

阅读:1

Abstract

BACKGROUND: This study aimed to investigate the prevalence of hepatitis B and C viruses in patients at the Shahid Motahari Clinic in Shiraz, Iran, from 2018 to 2022 using molecular diagnostic tests. MATERIALS AND METHODS: This cross-sectional study was conducted on patients who underwent polymerase chain reaction (PCR) molecular tests for the diagnosis of hepatitis B and C at the Shahid Motahari Clinic in Shiraz. A total of 538 PCR tests for hepatitis B and 457 tests for hepatitis C were administered. Among them, 69 patients diagnosed with hepatitis B virus (HBV) and 60 patients with HCV were selected for examination, and their clinical data were collected. RESULTS: The prevalence of HBV and hepatitis C virus (HCV) in the study population was 17.28% and 20.56%, respectively. Most infected patients were male, married, and of Fars ethnic background. The main risk factors for HBV were extramarital sex and a family history of hepatitis B or C, whereas the main risk factors for HCV included drug injection, blood transfusion, imprisonment, tattooing, and extramarital sex. The findings revealed that the two most common HCV subtypes were subtype 3b (72%) and subtype 1a (28%). CONCLUSION: The results showed that 17.28% of participants had HBV and 20.56% had HCV. The majority of those with HBV or HCV were male, Fars, and married. Patients with HBV had a high incidence of family members with hepatitis B/C, whereas those with HCV had a high incidence of transfusion, drug injection, tattooing, and imprisonment. The most common HCV subtypes were 3b and 1a.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。